BOPA is delighted to be working with UKCPA and Rheumatology Pharmacists UK on a joint Biosimilars study day in London on 1st November.
Full details of the day – ‘Biosimilars – How will Pharmacy face the challenge?’ including registration can be found at www.pharman.co.uk/events/2017/11/biosimilars-how-will-pharmacy-manage-the-challenge
The agenda will be emailed to BOPA members
The Royal Pharmaceutical Society (RPS) today (2nd April 2026) announced the appointment of Dr Justine Scanlan FRPharmS as its new Director of Pharmacy, a key leadership role as the organisation…
Abstract Submission for the 29th Annual BOPA Conference 2026 is now OPEN Delegates are invited to present results of their clinical and technical work as a poster with…
Helena Langford is a Fellow in Clinical AI and a Clinical Informatics Pharmacist at University Hospitals Bristol and Weston NHS Foundation Trust, with several years of experience in clinical informatics.…
First UK Campaign to Protect Healthcare Workers from Exposure to Hazardous Medicinal Products (HMPs) launches in Westminster London, 10 March 2026: Today, the Safer Healthcare and Biosafety Network (SHBN) launches…
The 29th BOPA Annual Conference in 2026 will be held at the ICC London Olympia on 2-4 October 2026.
Check out the latest information here: Latest Conference 2026 – BOPA
Everything you need to know
